Exploration of Pupil Dilation in Horner's Patients Taking Flomax
Sponsor: Denver Health and Hospital Authority
Terminated
incomplete enrollment
Other terminated trials from Denver Health and Hospital Authority
- Influenza · Phase NA · Mar 2025
- Venous Thromboembolism · Phase PHASE2 · Aug 2021
- Acute Lung Injury · Phase PHASE1 · Nov 2018
- Hemorrhagic Shock · Phase PHASE2 · Apr 2017
- Alcohol Withdrawal Syndrome · Phase PHASE3 · Jan 2017
See all terminations from Denver Health and Hospital Authority
A PHASE4 clinical study on Horner Syndrome, this trial is terminated or withdrawn. The trial is conducted by Denver Health and Hospital Authority and has accumulated 10 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE4
-
Apr 2022 — Dec 2022 [monthly]
Terminated PHASE4
▶ Show 5 earlier versions
-
Jan 2021 — Apr 2022 [monthly]
Terminated PHASE4
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Dec 2018 — Nov 2020 [monthly]
Recruiting PHASE4
-
Oct 2018 — Dec 2018 [monthly]
Recruiting PHASE4
-
Sep 2018 — Oct 2018 [monthly]
Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Denver Health and Hospital Authority
- University of Colorado, Denver
For direct contact, visit the study record on ClinicalTrials.gov .